MedPath
NMPA Approval

Oxcarbazepine Oral Suspension

国药准字H20253025

January 2, 2025

Drug Information

奥卡西平口服混悬液

口服混悬剂

100ml:6g

化学药品

January 2, 2025

Company Information

Applicant Company

湖北省武汉东湖新技术开发区生物园路8号

Manufacturing Company

湖北省武汉东湖新技术开发区生物园路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥卡西平口服混悬液 - NMPA 批准文号 | MedPath